Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W7LO
|
||||
Former ID |
DPR000092
|
||||
Drug Name |
PF9601N
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Phase 1 | [529304] | ||
Company |
Pfizer
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H18N2O
|
||||
Canonical SMILES |
C#CCNCC1=CC2=C(N1)C=CC(=C2)OCC3=CC=CC=C3
|
||||
InChI |
1S/C19H18N2O/c1-2-10-20-13-17-11-16-12-18(8-9-19(16)21-17)22-14-15-6-4-3-5-7-15/h1,3-9,11-12,20-21H,10,13-14H2
|
||||
InChIKey |
YFPNAYXYKXAKJC-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Amine oxidase [flavin-containing] B | Target Info | Inhibitor | [536923] | |
KEGG Pathway | Glycine, serine and threonine metabolism | ||||
Arginine and proline metabolism | |||||
Histidine metabolism | |||||
Tyrosine metabolism | |||||
Phenylalanine metabolism | |||||
Tryptophan metabolism | |||||
Drug metabolism - cytochrome P450 | |||||
Metabolic pathways | |||||
Serotonergic synapse | |||||
Dopaminergic synapse | |||||
Cocaine addiction | |||||
Amphetamine addiction | |||||
Alcoholism | |||||
Pathway Interaction Database | Alpha-synuclein signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.